These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19553085)

  • 1. Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.
    Smith SA; Waggoner AD; de las Fuentes L; Davila-Roman VG
    J Am Soc Echocardiogr; 2009 Aug; 22(8):883-9. PubMed ID: 19553085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease.
    Reid TE; Kumar K; Wang XS
    Curr Top Med Chem; 2013; 13(11):1353-62. PubMed ID: 23675941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.
    Hofmann C; Penner U; Dorow R; Pertz HH; Jähnichen S; Horowski R; Latté KP; Palla D; Schurad B
    Clin Neuropharmacol; 2006; 29(2):80-6. PubMed ID: 16614540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.
    Antonini A; Poewe W
    Lancet Neurol; 2007 Sep; 6(9):826-9. PubMed ID: 17706566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.
    Droogmans S; Roosens B; Cosyns B; Degaillier C; Hernot S; Weytjens C; Garbar C; Caveliers V; Pipeleers-Marichal M; Franken PR; Lahoutte T; Schoors D; Van Camp G
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1940-8. PubMed ID: 19346455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced valvular heart disease: an update.
    Andrejak M; Tribouilloy C
    Arch Cardiovasc Dis; 2013 May; 106(5):333-9. PubMed ID: 23769407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy.
    Cavero I; Guillon JM
    J Pharmacol Toxicol Methods; 2014; 69(2):150-61. PubMed ID: 24361689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of carcinoid heart disease identified by cardiac computed tomography.
    Davar J; Lazoura O; Caplin ME; Toumpanakis C
    J Cardiovasc Comput Tomogr; 2021; 15(2):167-174. PubMed ID: 33004299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
    Horvath J; Fross RD; Kleiner-Fisman G; Lerch R; Stalder H; Liaudat S; Raskoff WJ; Flachsbart KD; Rakowski H; Pache JC; Burkhard PR; Lang AE
    Mov Disord; 2004 Jun; 19(6):656-62. PubMed ID: 15197703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
    Zanettini R; Antonini A; Gatto G; Gentile R; Tesei S; Pezzoli G
    N Engl J Med; 2007 Jan; 356(1):39-46. PubMed ID: 17202454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanobiology of drug-induced cardiac valve disease.
    Lam NT; Balachandran K
    J Long Term Eff Med Implants; 2015; 25(1-2):27-40. PubMed ID: 25955005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating plasma and platelet 5-hydroxytryptamine in carcinoid heart disease: a pilot study.
    Bhattacharyya S; Jagroop A; Gujral DM; Hayward C; Toumpanakis C; Caplin M; Mikhailidis DP; Davar J
    J Heart Valve Dis; 2013 May; 22(3):400-7. PubMed ID: 24151767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic drugs and valvular heart disease.
    Rothman RB; Baumann MH
    Expert Opin Drug Saf; 2009 May; 8(3):317-29. PubMed ID: 19505264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?
    Ayme-Dietrich E; Lawson R; Da-Silva S; Mazzucotelli JP; Monassier L
    Pharmacol Res; 2019 Feb; 140():33-42. PubMed ID: 30208338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice.
    Mekontso-Dessap A; Brouri F; Pascal O; Lechat P; Hanoun N; Lanfumey L; Seif I; Benhaiem-Sigaux N; Kirsch M; Hamon M; Adnot S; Eddahibi S
    Circulation; 2006 Jan; 113(1):81-9. PubMed ID: 16380550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
    Kekewska A; Hübner H; Gmeiner P; Pertz HH
    J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Contemporary Valve Surgery in Patients with Carcinoid Heart Disease.
    Kuntze T; Owais T; Secknus MA; Kaemmerer D; Baum R; Girdauskas E
    J Heart Valve Dis; 2016 May; 25(3):356-363. PubMed ID: 27989047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptors and heart valve disease--it was meant 2B.
    Hutcheson JD; Setola V; Roth BL; Merryman WD
    Pharmacol Ther; 2011 Nov; 132(2):146-57. PubMed ID: 21440001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.
    Jian B; Xu J; Connolly J; Savani RC; Narula N; Liang B; Levy RJ
    Am J Pathol; 2002 Dec; 161(6):2111-21. PubMed ID: 12466127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.